Form 4: Twist Bioscience Executive Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report


Dennis Cho, Senior Vice President, Chief Legal Officer & Corporate Secretary of Twist Bioscience Corp, sold 125 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

  • Dennis Cho, an officer of Twist Bioscience Corp (TWST), executed a sale of common stock.
  • The transaction involved the disposition of 125 shares of common stock.
  • The shares were sold at a price of $36.193 per share.
  • Following this transaction, Dennis Cho beneficially owns 104,612 shares of common stock.
  • The sale was a "sell to cover" transaction, mandated by the issuer's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units, and was not a discretionary trade.
  • The transaction date was July 2, 2025.

Sentiment

Score: 5

Explanation: The transaction is a routine 'sell to cover' for tax purposes related to RSU vesting, which is a common and non-discretionary event for executives. It does not reflect a change in management's outlook or a discretionary sale of shares.

Future Outlook

No forward-looking statements or guidance regarding the company's future performance or strategic direction are provided.

Management Comments

  • The sale of 125 shares represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.
  • These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

This Form 4 filing, detailing an insider transaction, does not provide broader industry context or trends. It is a routine disclosure of an individual's stock activity.

Stakeholder Impact

  • Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in management's confidence or a significant reduction in beneficial ownership.

Key Dates

DateDescription
07/02/2025Date of earliest transaction for the sale of common stock.
07/07/2025Date the Form 4 was signed by the Attorney-in-Fact for Dennis Cho.

Keywords

Twist Bioscience, TWST, Dennis Cho, SEC Form 4, Insider Trading, Stock Sale, Restricted Stock Units, RSU, Tax Withholding, Sell to Cover

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.